Samuel Kerama

Samuel Kerama

Pharmacy & Poisons Board
Ministry of Health, Nairobi- Kenya

 
REGULATORY PARTNER
 
Samuel Kerama is a clinical pharmacist, and currently serves as a senior regulatory affairs expert at the Pharmacy and Poisons Board- Kenya. He holds a master’s degree in Clinical pharmacy from the university of Nairobi (Kenya) and a Master’s degree in Biotechnology Innovation and Regulatory Science from Purdue University (USA).

Kerama has actively been involved in regulation of medicines and health technologies for over 5 years in the areas of Good Manufacturing Practice, Bioequivalence assessment and pharmacovigilance, as well as a resource person within the East Africa (EAC) and Intergovernmental Authority on Development (IGAD) medicines regulatory harmonization forums. He has co-authored regulatory instruments on good distribution practices and management of pharmaceutical waste in Kenya.

He has a passion for professional development and mentorship in medicine safety and protection of the public health.

 

Corporate Information

The IAS PHARMA Inaugural Copyright 2024 is organized by Xcene Research, an African Contract Research Organization committed to providing clinical trials access to a more diverse population in Africa.

Contact Address

Xcene Research Corporate Office
1 Ogunsiji Close, S&B Tejuosho Estate, Allen Avenue Ikeja, Lagos Nigeria

Impact Africa Summit

Email: info@impactafricasummit.org

Quick Links

Follow Us On:

  • icon
  • icon
  • icon
  • icon

Hotel Accommodations

Hotel: Lagos Oriental Hotel
Address: 3 Lekki – Epe, Expy, Victoria Island, Lagos
Contact : +2347026960065
Discount Code : IASPharma23


Hotel: Tudor Hotel
Address: Lekki Phase 1
Contact : +2348167799210
Discount Code : IASPharma23


Transportation

Company : Sixth Motors
Contact: +2347035158901
Discount Code: IASPharma23


Venue Information


Signup For Updates

Get regular updates and hear the latest news and advancements from our team. Signup for email updates

 
Copyright © Copyright 2024 Impact Africa Summit. All Rights Reserved.